No Silver Bullet, ISPE Survey Confirms: Drug Shortages Require Shotgun Approach
This article was originally published in The Gold Sheet
Industry agrees FDA could help ameliorate drug shortages with quicker approval of new lines and relaxed enforcement, ISPE survey shows. There’s less enthusiasm for preventing shortages with backup contract manufacturers.
You may also be interested in...
As the main cause of drug shortages is poor manufacturing quality, the best way to prevent them is to get ahead of the curve on quality, says a Pew/ISPE industry survey report.
US HHS turns to COVID-19 vaccine distributor to assemble vaccine administration kits, citing revised vaccine delivery schedule.
Stand-alone bill headed for Senate, where it fared poorly in coronavirus response legislative packages.